• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE; CUTANEOUS TISSUE ADHESIVE WITH MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE; CUTANEOUS TISSUE ADHESIVE WITH MESH Back to Search Results
Catalog Number CLR422
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Local Reaction (2035)
Event Date 05/25/2021
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Additional information has been requested and obtained.If further details are received at a later date a supplemental medwatch will be sent.What is the procedure date? not provided.What date did the reaction occur on? exact date not provided, all reactions were approx 5-6 weeks post-op.Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription medication)? if so, please specify.No, only topical steroid applied.If medication was required, please clarify if it was prescribed or purchased over-the-counter.Prescribed.What is the most current patient status? not known.Can you identify the lot number of the product that was used? not provided.Was prineo/dermabond or skin adhesive used on the patient in a previous surgery or wound closure? not provided.Unfortunately no further information is available from hcp for this reported case.Please describe how was the adhesive was applied.What prep was used prior to, during or after prineo use? was a dressing placed over the incision? if so, what type of cover dressing used? is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? were any patch or sensitivity tests performed? patient demographics: id, gender, age or date of birth; bmi.Has the patient previously been exposed to similar glues/agents for repair, crafts, cosmetic use (lashes, nails)? unfortunately no further information is available from hcp for this reported case.No product available for return.Note: events reported on mw# 2210968-2021-07852, mw# 2210968-2021-07853, mw# 2210968-2021-07854.
 
Event Description
It was reported a patient underwent a total knee replacement on unknown date and topical skin adhesive was used.Post op 5-6 weeks, patient suffered atopic contact dermatitis after having adhesive used on their skin.Reaction noticed post-surgery.Prescription topical steroid applied.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE
Type of Device
CUTANEOUS TISSUE ADHESIVE WITH MESH
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km. 8.3
san lorenzo 00754
*   00754
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key12393116
MDR Text Key268979538
Report Number2210968-2021-07855
Device Sequence Number1
Product Code OMD
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K163645
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 08/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/31/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberCLR422
Was Device Available for Evaluation? No
Date Manufacturer Received08/08/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-